Performance of common genetic variants in breast-cancer risk models
- PMID: 20237344
- PMCID: PMC2921181
- DOI: 10.1056/NEJMoa0907727
Performance of common genetic variants in breast-cancer risk models
Erratum in
- N Engl J Med. 2010 Dec 2;363(23):2272
Abstract
Background: Genomewide association studies have identified multiple genetic variants associated with breast cancer. The extent to which these variants add to existing risk-assessment models is unknown.
Methods: We used information on traditional risk factors and 10 common genetic variants associated with breast cancer in 5590 case subjects and 5998 control subjects, 50 to 79 years of age, from four U.S. cohort studies and one case-control study from Poland to fit models of the absolute risk of breast cancer. With the use of receiver-operating-characteristic curve analysis, we calculated the area under the curve (AUC) as a measure of discrimination. By definition, random classification of case and control subjects provides an AUC of 50%; perfect classification provides an AUC of 100%. We calculated the fraction of case subjects in quintiles of estimated absolute risk after the addition of genetic variants to the traditional risk model.
Results: The AUC for a risk model with age, study and entry year, and four traditional risk factors was 58.0%; with the addition of 10 genetic variants, the AUC was 61.8%. About half the case subjects (47.2%) were in the same quintile of risk as in a model without genetic variants; 32.5% were in a higher quintile, and 20.4% were in a lower quintile.
Conclusions: The inclusion of newly discovered genetic factors modestly improved the performance of risk models for breast cancer. The level of predicted breast-cancer risk among most women changed little after the addition of currently available genetic information.
2010 Massachusetts Medical Society
Figures

Comment in
-
A tiny step closer to personalized risk prediction for breast cancer.N Engl J Med. 2010 Mar 18;362(11):1043-5. doi: 10.1056/NEJMe0912474. N Engl J Med. 2010. PMID: 20237351 No abstract available.
Similar articles
-
Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.J Natl Cancer Inst. 2010 Nov 3;102(21):1618-27. doi: 10.1093/jnci/djq388. Epub 2010 Oct 18. J Natl Cancer Inst. 2010. PMID: 20956782 Free PMC article.
-
Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women.J Natl Cancer Inst. 2010 Jul 7;102(13):972-81. doi: 10.1093/jnci/djq170. Epub 2010 May 18. J Natl Cancer Inst. 2010. PMID: 20484103 Free PMC article.
-
Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.Hum Genet. 2013 May;132(5):523-36. doi: 10.1007/s00439-013-1269-4. Epub 2013 Jan 25. Hum Genet. 2013. PMID: 23354978 Free PMC article.
-
Polygenic risk prediction models for colorectal cancer: a systematic review.BMC Cancer. 2022 Jan 15;22(1):65. doi: 10.1186/s12885-021-09143-2. BMC Cancer. 2022. PMID: 35030997 Free PMC article.
-
Performance of Single-Nucleotide Polymorphisms in Breast Cancer Risk Prediction Models: A Systematic Review and Meta-analysis.Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):506-521. doi: 10.1158/1055-9965.EPI-18-0810. Epub 2018 Dec 18. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 30563826
Cited by
-
Genetic susceptibility to triple-negative breast cancer.Cancer Res. 2013 Apr 1;73(7):2025-30. doi: 10.1158/0008-5472.CAN-12-1699. Epub 2013 Mar 27. Cancer Res. 2013. PMID: 23536562 Free PMC article. Review.
-
Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study.Breast Cancer Res Treat. 2013 Feb;138(1):249-59. doi: 10.1007/s10549-013-2428-y. Epub 2013 Feb 3. Breast Cancer Res Treat. 2013. PMID: 23378108 Free PMC article.
-
Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patients.PLoS One. 2015 Mar 23;10(3):e0122657. doi: 10.1371/journal.pone.0122657. eCollection 2015. PLoS One. 2015. PMID: 25799416 Free PMC article.
-
Two-stage breast cancer screening in the developing world.World J Surg. 2011 Mar;35(3):698-9. doi: 10.1007/s00268-010-0808-6. World J Surg. 2011. PMID: 20857103 No abstract available.
-
Precision Therapy of Head and Neck Squamous Cell Carcinoma.J Dent Res. 2018 Jun;97(6):614-621. doi: 10.1177/0022034518769645. Epub 2018 Apr 12. J Dent Res. 2018. PMID: 29649374 Free PMC article. Review.
References
-
- Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151:716–26. - PubMed
-
- ACOG practice bulletin no. 103: hereditary breast and ovarian cancer syndrome. Obstet Gynecol. 2009;113:957–66. - PubMed
-
- Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–86. - PubMed
-
- Gail MH, Benichou J. Validation studies on a model for breast cancer risk. J Natl Cancer Inst. 1994;86:573–5. Erratum, J Natl Cancer Inst 1994;86:803. - PubMed
Publication types
MeSH terms
Grants and funding
- P01 CA087969/CA/NCI NIH HHS/United States
- N01 WH022110/WH/WHI NIH HHS/United States
- R01 CA49449/CA/NCI NIH HHS/United States
- U01 CA098233/CA/NCI NIH HHS/United States
- U01CA098233/CA/NCI NIH HHS/United States
- U01 CA098710/CA/NCI NIH HHS/United States
- P01 CA53996/CA/NCI NIH HHS/United States
- P01 CA053996/CA/NCI NIH HHS/United States
- P01 CA87969/CA/NCI NIH HHS/United States
- U01CA098710/CA/NCI NIH HHS/United States
- R01 CA049449/CA/NCI NIH HHS/United States
- ZIA CP010188/ImNIH/Intramural NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical